# Highest return on equity in Latvia: Manufacture of basic pharmaceutical products and pharmaceutical preparations, 2024

The list includes 11 of 11 companies that met the conditions. First place: Sabiedrība ar ierobežotu atbildību "LMP" (99,9 %).

- Indicator: Net profit as a percentage of equity at year end.
- Criterion: Equity at least 100 000 €.
- Criterion: Turnover at least 1 m €.
- Data: 2026-11-17
- URL: https://regmio.eu/en/top/lv/return-on-equity/nace/21/2024

| # | Company | Reg. no. | Region | Return on equity |
|---|---|---|---|---|
| 1 | Sabiedrība ar ierobežotu atbildību "LMP" | 40103046409 | Rīga | 99,9 % |
| 2 | Sabiedrība ar ierobežotu atbildību "BALTIJAS TERAPEITISKAIS SERVISS" | 40003174110 | Rīga | 66,4 % |
| 3 | SIA "Solepharm" | 40103209086 | Mārupes novads | 35,1 % |
| 4 | SIA "Lotos Pharma" | 40103638962 | Mārupes novads | 27,7 % |
| 5 | Akciju sabiedrība "Olpha" (K) | 40003007246 | Olaines novads | 16,0 % |
| 6 | AS "RĪGAS FARMACEITISKĀ FABRIKA" | 40003000765 | Rīga | 8,9 % |
| 7 | SIA "SILVANOLS" | 40003233170 | Rīga | 8,0 % |
| 8 | Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" | 40003264804 | Rīga | 7,6 % |
| 9 | Sabiedrība ar ierobežotu atbildību "AD smart" | 50103372961 | Mārupes novads | 7,6 % |
| 10 | Liepājas speciālās ekonomiskās zonas SIA "NordePlast" | 42103074684 | Liepāja | 5,2 % |
| 11 | Sabiedrība ar ierobežotu atbildību "PHARMIDEA" | 40003791173 | Olaines novads | 4,9 % |

K — for this year the company has filed only a consolidated (group) report, which also includes subsidiaries' data. If the company's own report is also available, the list uses that.
